Despite reports that COVID-19 vaccines cause blood abnormalities, the American Red Cross and the U.S. Food and Drug Administration continue to brush off concerns that the massive vaccine campaign may have contaminated the country’s blood supply.
As of mid-September, the Vaccine Adverse Event Reporting System (VAERS) — notorious for capturing only a minuscule proportion of adverse events — had received notification of more than 43,000 blood clotting disorders, including acute-onset problems in young children.
Clotting disorders make the blood clot “too easily,” generating clots that can travel through the bloodstream and increase the risk of heart attacks and strokes, among other potential complications.
Funeral directors and embalmers in the U.S. and U.K. have gone public with shocking descriptions of highly unusual blood clots in up to 85% of the bodies coming under their care — a “massive increase” compared to pre-COVID-19 vaccine times when ordinary-looking clots might be found in 5% to 10% of the deceased.
“In all my years of embalming, we would run across clots from time to time,” said Richard Hirschman, an experienced funeral director in Alabama, “but since May last year , something about the blood has changed. It’s not normal. It’s drastic.”
The rampant clotting and the clots’ disturbing sci-fi appearance — “long fibrous entities that can completely block a vein or artery,” which Hirschman likens to calamari, rubber bands, spaghetti, worms or parasites — are just some of the concerns prompting questions about blood supply safety.
No ‘safety risks?’
About 55% of blood is plasma — which, among other functions, supplies proteins “for blood clotting and immunity” — with the remaining 45% consisting of red blood cells, white blood cells and platelets suspended in the plasma.
Depending on their blood type, individuals who give blood can choose to donate whole blood, plasma or platelets, or they can make a “Power Red” donation (a “concentrated dose” of red blood cells).
The American Red Cross says it will not accept blood from someone whose blood “does not clot normally,” but — following guidance from the same branch of the FDA that oversees vaccines — welcomes immediate donations from anyone who received one of the mRNA or other COVID-19 vaccines available in the U.S., as long as the person says he is “symptom-free and feeling well.”
The Red Cross claims to be independent but openly celebrates its “special relationship” with the federal government — a relationship that includes periodic appropriations and contracts.
In a recent tweet directed at potential blood transfusion recipients, the Red Cross clarified:
The tweet generated numerous responses from the public accusing the Red Cross of disseminating “misinformation” and directing the organization’s attention to peer-reviewed publications contradicting its languid attitude.
In one of the most alarming studies, published in August in the International Journal of Vaccine Theory, Practice, and Research, Italian surgeons described atypical clumping of red blood cells and the presence of “extraordinarily anomalous structures and substances” of “various shapes and sizes of unclear origin” in over 94% of symptomatic, COVID-19-vaccinated individuals whose blood they examined.
The 1,006 study participants, ranging in age from 15 to 85, received a first (14%), second (45%) or third (41%) dose of a Pfizer or Moderna mRNA vaccine about a month before the analysis of their blood.
Pointing to other studies that found foreign materials in the blood of COVID-19 vaccine recipients and in COVID-19 vaccine vials — materials “that the CDC [Centers for Disease Control and Prevention] and the many promoters of the experimental injections claimed were not in them at all” — the Italian authors concluded the vaccine-induced blood alterations were “likely … to be involved in producing the coagulation disorders commonly reported after anti-COVID injections.”
Putting the matter even more plainly, they stated:
“[S]uch abrupt changes as we have documented in the peripheral blood profile of 948 patients have never been observed after inoculation by any vaccines in the past according to our clinical experience. The sudden transition … from a state of perfect normalcy to a pathological one … is unprecedented. …
“In our collective experience, and in our shared professional opinion, the large quantity of particles in the blood of mRNA injection recipients is incompatible with normal blood flow especially at the level of the capillaries.”
Another study by Romanian researchers, sent to the Red Cross by the tweeting public, not only reported that Pfizer’s “vaccine-associated synthetic mRNA persists in systemic circulation for at least 2 weeks” but also noted, “extended plasma clearance times compared to estimates presented by mRNA vaccine manufacturers.”
Meanwhile, a case report from Germany presenting autopsy results for a man who died after receiving three “gene-based” COVID-19 vaccine doses (one AstraZeneca, two Pfizer) over a seven-month period conclusively revealed the presence of COVID-19 vaccine spike protein in both brain and heart — and particularly in small blood vessel cells.
These and other studies may be why members of the public like “Mary” incredulously tweeted back to the Red Cross, “Are you kidding? There is proof it enters other body cells like the heart, causing myocarditis; how do you think it gets to the heart from the injection site???”
The FDA has refused to release autopsy results in its possession for people who died following COVID-19 vaccination.
Out, damned clot
As early as May 2021, vaccine researchers were disclosing the “unexpected” entry into the bloodstream of the vaccines’ synthetic spike protein, while other pharmaceutical industry consultants admitted, “Some of the vaccine dose is going to make it into the bloodstream, of course.”
Around the same time, figures like Canadian physician Dr. Charles Hoffe were warning that technologies like CT scans and MRIs, which can identify large blood clots, would not find the “microscopic” clots affecting many of the COVID-19-vaccinated, who might “have no idea they are even having these microscopic blood clots.”
Hoffe was able to ascertain the widespread presence of micro-blood clots in his mRNA-vaccinated patient population using D-dimer tests that look for protein fragments associated with clots.
The Canadian doctor also cautioned that when blood clots damage the brain, spinal cord, heart or lungs, “those tissues … are permanently damaged.”
A year after these admissions, in May 2022, the FDA finally acknowledged the risk of “potentially life-threatening blood clots” in recipients of the Janssen/Johnson & Johnson (J&J) COVID-19 vaccine.
The European Medicines Agency (EMA) issued similar advisories about AstraZeneca’s COVID-19 vaccine.